Related Experiment Video

Updated: Mar 8, 2026

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

20.3K

Staged hybrid ablation for persistent and longstanding persistent atrial fibrillation effectively restores sinus

Michal Zembala1, Krzysztof Filipiak1, Oskar Kowalski1

  • 1Department of Cardiac Surgery and Transplantology, Silesian Center For Heart Diseases, Zabrze, Poland.

Archives of Medical Science : AMS
|February 2, 2017
PubMed

Insights

Hybrid ablation (HABL) is a safe and effective treatment for persistent atrial fibrillation (AF). This minimally invasive procedure combines epicardial and endocardial ablation, restoring sinus rhythm in most patients after one year.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Minimally Invasive Surgery

Background:

  • Persistent (PSAF) and longstanding persistent atrial fibrillation (LSPAF) present therapeutic challenges.
  • Hybrid ablation (HABL) integrates endoscopic epicardial and CARTO-guided endocardial ablation.
  • HABL aims to overcome limitations of existing AF treatments.

Purpose of the Study:

  • To evaluate the safety and feasibility of HABL.
  • To assess the effectiveness of HABL in PSAF and LSPAF patients.
  • To determine 1-year outcomes of HABL for atrial fibrillation.

Main Methods:

  • Prospective, single-center clinical registry study.
  • 90 patients with PSAF (n=39) and LSPAF (n=51) underwent HABL.
  • Follow-up included 3-, 6-, and 12-month assessments with Holter monitoring.

Main Results:

  • 86% of patients achieved sinus rhythm (SR) at 12 months.
  • 62.3% were in SR and off antiarrhythmic drugs (AADs) at 1 year.
  • Significant reduction in left atrial dimension and increase in left ventricular ejection fraction (LVEF) observed.

Conclusions:

  • HABL is a safe and effective treatment option for PSAF and LSPAF.
  • Combining epicardial and endocardial ablation restores sinus rhythm.
  • Consider HABL for persistent and longstanding persistent atrial fibrillation.
Abstract

Keywords:
ablationatrial fibrillationhybrid procedurespulmonary vein isolation

More Related Videos

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.9K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.2K

Related Concept Videos

Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.4K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
734
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
551
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
564
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
708
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
593